Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:2921-2926

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auerbach, M. A.
Right arrow Articles by Czernin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auerbach, M. A.
Right arrow Articles by Czernin, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Nuclear Scans
Related Collections
Right arrow PET and SPECT
Right arrow Chronic ischemic heart disease

(Circulation. 1999;99:2921-2926.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients With Ischemic Cardiomyopathy

Martin Allen Auerbach, MD; Heiko Schöder, MD; Carl Hoh, MD; Sanjiv Sam Gambhir, MD; Shariar Yaghoubi, BS; Jim W. Sayre, PhD; Daniel Silverman, MD; Michael E. Phelps, PhD; Heinrich R. Schelbert, MD; Johannes Czernin, MD

From the Ahmanson Biological Imaging Clinic/Nuclear Medicine, Department of Molecular and Medical Pharmacology, UCLA School of Medicine and Long Beach Community Medical Center, Los Angeles, Calif.

Correspondence to Johannes Czernin, MD, UCLA School of Medicine, AR-259 CHS, Los Angeles, CA 90095-6942.

Background—Detection of myocardial viability is important in patients with ischemic cardiomyopathy. Restoration of blood flow to viable myocardium is associated with improved left ventricular function and improved patient prognosis. However, the prevalence of viable myocardium in patients with ischemic cardiomyopathy is unknown.

Methods and Results—To determine the prevalence of myocardial viability, clinical [13N]ammonia/18F-deoxyglucose PET studies performed in 283 patients (age, 63±10 years) with ischemic heart disease (mean ejection fraction, 26±8%) were visually analyzed for the presence and extent of viable and nonviable myocardium. The myocardium was divided into 19 segments. The extent of viable myocardium was considered "functionally" significant if >=5 segments ({approx}25% of the left ventricular myocardium) exhibited a blood flow/metabolism mismatch and "prognostically" significant if 1 to 4 left ventricular segments did so. Of all patients, 41% had no evidence of viable myocardium, 55% had viable myocardium, and 4% had normal blood flow and metabolism within an enlarged left ventricle. Functionally significant viability was found in 27% and prognostically significant viability in 28% of the patients. Multivariate analysis revealed the presence of angina to be the only clinical parameter associated with the presence of functionally significant viability.

Conclusions—Revascularization might improve patient prognosis in 55% and result in improved left ventricular function in 27% of all patients with ischemic cardiomyopathy.


Key Words: coronary disease • viability • myocardium • tomography • cardiomyopathy




This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
T.-C. Hung, Y. Suzuki, T. Urashima, A. Caffarelli, G. Hoyt, A. Y. Sheikh, A. C. Yeung, I. Weissman, R. C. Robbins, J. M. Bulte, et al.
Multimodality Evaluation of the Viability of Stem Cells Delivered Into Different Zones of Myocardial Infarction
Circ Cardiovasc Imaging, July 1, 2008; 1(1): 6 - 13.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. G. Camici, S. K. Prasad, and O. E. Rimoldi
Stunning, Hibernation, and Assessment of Myocardial Viability
Circulation, January 1, 2008; 117(1): 103 - 114.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. J. Velazquez, K. L. Lee, C. M. O'Connor, J. K. Oh, R. O. Bonow, G. M. Pohost, A. M. Feldman, D. B. Mark, J. A. Panza, G. Sopko, et al.
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1540 - 1547.e4.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. F.L. Schinkel, D. Poldermans, A. Elhendy, and J. J. Bax
Assessment of Myocardial Viability in Patients with Heart Failure
J. Nucl. Med., July 1, 2007; 48(7): 1135 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Fallavollita, B. J. Riegel, G. Suzuki, U. Valeti, and J. M. Canty Jr.
Mechanism of sudden cardiac death in pigs with viable chronically dysfunctional myocardium and ischemic cardiomyopathy
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2688 - H2696.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Shah, F. G. Akar, and G. F. Tomaselli
Molecular Basis of Arrhythmias
Circulation, October 18, 2005; 112(16): 2517 - 2529.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Dib, R. E. Michler, F. D. Pagani, S. Wright, D. J. Kereiakes, R. Lengerich, P. Binkley, D. Buchele, I. Anand, C. Swingen, et al.
Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up
Circulation, September 20, 2005; 112(12): 1748 - 1755.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. J. Luisi Jr., G. Suzuki, R. deKemp, M. S. Haka, S. A. Toorongian, J. M. Canty Jr., and J. A. Fallavollita
Regional 11C-Hydroxyephedrine Retention in Hibernating Myocardium: Chronic Inhomogeneity of Sympathetic Innervation in the Absence of Infarction
J. Nucl. Med., August 1, 2005; 46(8): 1368 - 1374.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J J Bax, E E van der Wall, and M Harbinson
Radionuclide techniques for the assessment of myocardial viability and hibernation
Heart, August 1, 2004; 90(suppl_5): v26 - v33.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Canty Jr, G. Suzuki, M. D. Banas, F. Verheyen, M. Borgers, and J. A. Fallavollita
Hibernating Myocardium: Chronically Adapted to Ischemia but Vulnerable to Sudden Death
Circ. Res., April 30, 2004; 94(8): 1142 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. F. L. Schinkel, D. Poldermans, V. Rizzello, J.-L. J. Vanoverschelde, A. Elhendy, E. Boersma, J. R.T.C. Roelandt, and J. J. Bax
Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Murashita, Y. Makino, Y. Kamikubo, K. Yasuda, M. Mabuchi, and N. Tamaki
Quantitative gated myocardial perfusion single photon emission computed tomography improves the prediction of regional functional recovery in akinetic areas after coronary bypass surgery: useful tool for evaluation of myocardial viability
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1328 - 1334.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. H. Cole, J. I. Miller III, L. S. Sperling, and W. S. Weintraub
Long-term follow-up of coronary artery disease presenting in young adults
J. Am. Coll. Cardiol., February 19, 2003; 41(4): 521 - 528.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. S. B. Beanlands, T. D. Ruddy, R. A. deKemp, R. M. Iwanochko, G. Coates, M. Freeman, C. Nahmias, P. Hendry, R. J. Burns, A. Lamy, et al.
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1735 - 1743.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A F L Schinkel, J J Bax, F B Sozzi, E Boersma, R Valkema, A Elhendy, J R T C Roelandt, and D Poldermans
Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction
Heart, August 1, 2002; 88(2): 125 - 130.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. B. Jacklin, S. F. Barrington, J. C. Roxburgh, G. Jackson, D. Sariklis, P. A. West, and M. N. Maisey
Cost-effectiveness of preoperative positron emission tomography in ischemic heart disease
Ann. Thorac. Surg., May 1, 2002; 73(5): 1403 - 1409.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. C. Allman, L. J. Shaw, R. Hachamovitch, and J. E. Udelson
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1151 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. F. Kofoed, R. Bangsgaard, S. Carstensen, J. H. Svendsen, P. R. Hansen, H. Arendrup, B. Hesse, and H. Kelbaek
Prolonged ischemic heart disease and coronary artery bypass -- relation to contractile reserve
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Schulz and G Heusch
Hibernating myocardium
Heart, December 1, 2000; 84(6): 587 - 594.
[Full Text]


Home page
CirculationHome page
A. Al-Mohammad, M. S. Walton, J. Czernin, M. M. A. Auerbach, H. Schoder, C. Hoh, S. S. Gambhir, S. Yaghoubi, J. W. Sayre, D. Silverman, et al.
Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients With Ischemic Cardiomyopathy Response
Circulation, July 25, 2000; 102 (4): e31 - e31.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Barnes, D. P. Dutka, M. Khan, P. G. Camici, and R. J. Hall
Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1603 - H1608.
[Abstract] [Full Text] [PDF]